Allergy Therapeutics PLC (GB:AGY)
LSE:AGY
Pq Grass
Seasonal Allergic Rhinitis, Rhinoconjunctivitis
Phase III
Completed
Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen
Sep 01, 2022
―
Pq Grass
Rhinitis, Allergic, Seasonal
Phase II/III
Completed
An Exploratory Study of PQ Grass 27600 SU
Oct 08, 2020
―
Grass Mata Mpl
Seasonal Allergic Rhinitis
Phase I
Completed
A Study of Tolerability and Safety of a New Cumulative Dose of Grass MATA MPL
Mar 29, 2017
―
Grass Mata Mpl 5100Su, Grass Mata Mpl 10200Su, Grass Mata Mpl 18200Su, Grass Mata 5100Su
Seasonal Allergic Rhinitis
Phase II
Completed
Dose Selection Study of Efficacy and Safety of Different Doses of Grass MATA MPL and Grass MATA Using mEECs™
Oct 20, 2015
―
Grass Mata Mpl 10200, Grass Mata Mpl 18200
Allergic Rhinitis
Phase I
Completed
A Study of Tolerability and Safety of Two New Doses of Grass MATA MPL
Sep 15, 2015
―
Tree Mata Mpl Or Tree Mata
Type I Hypersensitivity
Phase II
Terminated
Investigation of Efficacy and Safety of Tree MATAMPL,Tree MATA, and Placebo in Patients With Birch-Induced Seasonal Allergic Rhinitis
Oct 12, 2006
―
Ragweedmatampl
Type I Hypersensitivity
Phase II
Completed
Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick Test
Nov 25, 2005
―
Grass Matampl
Type I Hypersensitivity
Phase II
Completed
Different Doses of Tyrosine Adsorbed Grass Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Grass Pollen
Aug 22, 2005
―
Grass Mata Mpl
Type I Hypersensitivity
Phase II
Completed
Assessment of the Contribution of Monophosphoryl Lipid A (MPL) to a Grass Pollen Allergy Vaccine
Aug 22, 2005
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Allergy Therapeutics PLC (AGY) have in its pipeline
AGY is currently developing the following drugs: Pq Grass, Vlp Peanut, Pq Grass. These drug candidates are in various stages of clinical development as the company works toward FDA approval.